Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release version in the history. This update does not change the underlying study content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the version history.SummaryDifference0.2%

- Check45 days agoChange DetectedVisual/UI adjustments to the Record History page without any changes to study data or statuses.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check74 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 in the page footer. - No impact on study data or user workflow.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.